ArticleDermatology and therapy2024

Dupilumab Reduces Urticaria Activity, Itch, and Hives in Patients with Chronic Spontaneous Urticaria Regardless of Baseline Serum Immunoglobulin E Levels.

Marcus Maurer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.